Robert DeSantis - Intuitive Surgical Ex Officer
IUI1 Stock | EUR 503.30 2.30 0.45% |
Insider
Robert DeSantis is Ex Officer of Intuitive Surgical
Age | 57 |
Phone | 408 523 2100 |
Web | https://www.intuitive.com |
Robert DeSantis Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert DeSantis against Intuitive Surgical stock is an integral part of due diligence when investing in Intuitive Surgical. Robert DeSantis insider activity provides valuable insight into whether Intuitive Surgical is net buyers or sellers over its current business cycle. Note, Intuitive Surgical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Intuitive Surgical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert DeSantis over three months ago Disposition of 119 shares by Robert DeSantis of Intuitive Surgical at 229. subject to Rule 16b-3 | ||
Robert DeSantis over three months ago Disposition of 188 shares by Robert DeSantis of Intuitive Surgical at 290.33 subject to Rule 16b-3 | ||
Robert DeSantis over six months ago Disposition of 360 shares by Robert DeSantis of Intuitive Surgical subject to Rule 16b-3 | ||
Robert DeSantis over six months ago Disposition of tradable shares by Robert DeSantis of Intuitive Surgical at 179.7 subject to Rule 16b-3 |
Intuitive Surgical Management Efficiency
The company has return on total asset (ROA) of 0.0756 % which means that it generated a profit of $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1166 %, meaning that it generated $0.1166 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Brett Sandercock | ResMed Inc | 56 | |
Manohar Kuppusami | Sartorius Aktiengesellschaft | N/A | |
Manfred Werner | Sartorius Aktiengesellschaft | N/A | |
Amy Wakeham | ResMed Inc | N/A | |
BE MBA | Resmed Inc DRC | 50 | |
Petra Kirchhoff | Sartorius Aktiengesellschaft | 54 | |
Rashid Maqbool | Sartorius Aktiengesellschaft | N/A | |
Kaushik Ghoshal | ResMed Inc | 55 | |
Urvashi Tyagi | ResMed Inc | N/A | |
Rainer Lehmann | Sartorius Aktiengesellschaft | 48 | |
Constance Bienfait | Resmed Inc DRC | N/A | |
BE MBA | ResMed Inc | 50 | |
Heiko Imhl | Sartorius Stedim Biotech | N/A | |
Joachim Kreuzburg | Sartorius Aktiengesellschaft | 58 | |
David Pendarvis | ResMed Inc | 64 | |
Pascale Boissel | Sartorius Stedim Biotech | N/A | |
Amelie Buton | Sartorius Stedim Biotech | 32 | |
Mei Wang | Sartorius Aktiengesellschaft | N/A | |
John Mackay | Sartorius Stedim Biotech | 61 | |
AM AM | ResMed Inc | 80 | |
John Mackay | Sartorius Aktiengesellschaft | 61 |
Management Performance
Return On Equity | 0.12 | |||
Return On Asset | 0.0756 |
Intuitive Surgical Leadership Team
Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Rosa, Ex Officer | ||
Gary Guthart, CEO Pres | ||
Philip Kim, Head Relations | ||
Julian Nikolchev, Sr Strategy | ||
Jamie Samath, VP CFO | ||
MD FACS, Ex Officer | ||
Gary Loeb, G Officer | ||
Robert DeSantis, Ex Officer | ||
Fredrik Widman, Principal VP | ||
Marshall Mohr, Exec Services |
Intuitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.12 | |||
Return On Asset | 0.0756 | |||
Profit Margin | 0.21 % | |||
Operating Margin | 0.26 % | |||
Current Valuation | 86.49 B | |||
Shares Outstanding | 350.39 M | |||
Shares Owned By Insiders | 0.50 % | |||
Shares Owned By Institutions | 88.20 % | |||
Price To Earning | 44.64 X | |||
Price To Book | 8.30 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Intuitive Stock
When determining whether Intuitive Surgical is a strong investment it is important to analyze Intuitive Surgical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Intuitive Surgical's future performance. For an informed investment choice regarding Intuitive Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.